FGF2 Prevents Sunitinib-Induced Cardiotoxicity in Zebrafish and Cardiomyoblast H9c2 Cells

Stem cells with FGF4-bFGF fused gene enhances the expression of bFGF and improves myocardial repair in rats

(2014) Xiang-Qi Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A novel Danshensu derivative confers cardioprotection via PI3K/Akt and Nrf2 pathways

(2013) Guozhen Cui et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms

(2012) Ioannis Anestopoulos et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Conservation and Early Expression of Zebrafish Tyrosine Kinases Support the Utility of Zebrafish as a Model for Tyrosine Kinase Biology

(2012) Anil Kumar Challa et al.   Zebrafish

A Novel Preclinical Strategy for Identifying Cardiotoxic Kinase Inhibitors and Mechanisms of Cardiotoxicity

(2011) Hui Cheng et al.   CIRCULATION RESEARCH

Bone Morphogenetic Protein-1 Processes Insulin-like Growth Factor-binding Protein 3

(2011) Byoungjae Kim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes

(2011) Thomas Force et al.   NATURE REVIEWS DRUG DISCOVERY

14 EMF: Human Recombinant Low Molecular Weight Fibroblast Growth Factor 2 Protects the Heart From Reperfusion Injury Through Activation of FGF Receptors and Nitric Oxide Signaling

(2010) S.L. House et al.   ANNALS OF EMERGENCY MEDICINE

The use of imatinib mesylate has no adverse effects on the heart function. Results of a pilot study in patients with chronic myeloid leukemia

(2010) Milena Soriano Marcolino et al.   LEUKEMIA RESEARCH

Differences in Effects on Myocardium and Mitochondria by Angiogenic Inhibitors Suggest Separate Mechanisms of Cardiotoxicity

(2010) Kevin J. French et al.   TOXICOLOGIC PATHOLOGY

Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib

(2009) J.-Y. Blay   ANNALS OF ONCOLOGY

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors

(2009) R Kumar et al.   BRITISH JOURNAL OF CANCER

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate

(2008) M. L. Telli et al.   ANNALS OF ONCOLOGY

CREB Activation and Ischaemic Preconditioning

(2008) E. Marais et al.   CARDIOVASCULAR DRUGS AND THERAPY

A quantitative analysis of kinase inhibitor selectivity

(2008) Mazen W Karaman et al.   NATURE BIOTECHNOLOGY